# A Bioavailability Study of LY2452473 and Tadalafil

> **NCT01401543** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 24 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** LY2452473
- **DRUG:** Tadalafil
- **DRUG:** LY900010

## Key facts

- **NCT ID:** NCT01401543
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01401543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01401543, "A Bioavailability Study of LY2452473 and Tadalafil". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01401543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*